PubMed:9032271
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-104 | Sentence | denotes | Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. |
| T2 | 105-255 | Sentence | denotes | Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). |
| T3 | 256-352 | Sentence | denotes | Associated with its inhibitor, I kappaB, NF-kappaB resides as an inactive form in the cytoplasm. |
| T4 | 353-492 | Sentence | denotes | Upon stimulation by various agents, I kappaB is proteolyzed and NF-kappaB translocates to the nucleus, where it activates its target genes. |
| T5 | 493-579 | Sentence | denotes | The transduction pathways that lead to I kappaB inactivation remain poorly understood. |
| T6 | 580-748 | Sentence | denotes | In this study, we have characterized a cellular mutant, the 70/Z3-derived 1.3E2 murine pre-B cell line, that does not activate NF-kappaB in response to several stimuli. |
| T7 | 749-988 | Sentence | denotes | We demonstrate that upon stimulation by lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced phosphorylation on serines 32 and 36. |
| T8 | 989-1153 | Sentence | denotes | Neither a mutation in I kappaB alpha nor a mutation in p50 or relA, the two major subunits of NF-kappaB in this cell line, accounts for this phosphorylation defect. |
| T9 | 1154-1375 | Sentence | denotes | As well as culminating in the inducible phosphorylation of I kappaB alpha on serines 32 and 36, all the stimuli that are inactive on 1.3E2 cells exhibit a sensitivity to the antioxidant pyrrolidine dithiocarbamate (PDTC). |
| T10 | 1376-1531 | Sentence | denotes | In contrast, stimuli such as hyperosmotic shock or phosphatase inhibitors, which use PDTC-insensitive pathways, induce I kappaB alpha degradation in 1.3E2. |
| T11 | 1532-1622 | Sentence | denotes | Analysis of the redox status of 1.3E2 does not reveal any difference from wild-type 70Z/3. |
| T12 | 1623-1834 | Sentence | denotes | We also report that the human T-cell leukemia virus type 1 (HTLV-1)-derived Tax trans-activator induces NF-kappaB activity in 1.3E2, suggesting that this viral protein does not operate via the defective pathway. |
| T13 | 1835-2009 | Sentence | denotes | Finally, we show that two other I kappaB molecules, I kappaB beta and the recently identified I kappaB epsilon, are not degraded in the 1.3E2 cell line following stimulation. |
| T14 | 2010-2177 | Sentence | denotes | Our results demonstrate that 1.3E2 is a cellular transduction mutant exhibiting a defect in a step that is required by several different stimuli to activate NF-kappaB. |
| T15 | 2178-2331 | Sentence | denotes | In addition, this analysis suggests a common step in the signaling pathways that trigger I kappaB alpha, I kappaB beta, and I kappaB epsilon degradation. |
| T1 | 0-104 | Sentence | denotes | Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. |
| T2 | 105-255 | Sentence | denotes | Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). |
| T3 | 256-352 | Sentence | denotes | Associated with its inhibitor, I kappaB, NF-kappaB resides as an inactive form in the cytoplasm. |
| T4 | 353-492 | Sentence | denotes | Upon stimulation by various agents, I kappaB is proteolyzed and NF-kappaB translocates to the nucleus, where it activates its target genes. |
| T5 | 493-579 | Sentence | denotes | The transduction pathways that lead to I kappaB inactivation remain poorly understood. |
| T6 | 580-748 | Sentence | denotes | In this study, we have characterized a cellular mutant, the 70/Z3-derived 1.3E2 murine pre-B cell line, that does not activate NF-kappaB in response to several stimuli. |
| T7 | 749-988 | Sentence | denotes | We demonstrate that upon stimulation by lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced phosphorylation on serines 32 and 36. |
| T8 | 989-1153 | Sentence | denotes | Neither a mutation in I kappaB alpha nor a mutation in p50 or relA, the two major subunits of NF-kappaB in this cell line, accounts for this phosphorylation defect. |
| T9 | 1154-1375 | Sentence | denotes | As well as culminating in the inducible phosphorylation of I kappaB alpha on serines 32 and 36, all the stimuli that are inactive on 1.3E2 cells exhibit a sensitivity to the antioxidant pyrrolidine dithiocarbamate (PDTC). |
| T10 | 1376-1531 | Sentence | denotes | In contrast, stimuli such as hyperosmotic shock or phosphatase inhibitors, which use PDTC-insensitive pathways, induce I kappaB alpha degradation in 1.3E2. |
| T11 | 1532-1622 | Sentence | denotes | Analysis of the redox status of 1.3E2 does not reveal any difference from wild-type 70Z/3. |
| T12 | 1623-1834 | Sentence | denotes | We also report that the human T-cell leukemia virus type 1 (HTLV-1)-derived Tax trans-activator induces NF-kappaB activity in 1.3E2, suggesting that this viral protein does not operate via the defective pathway. |
| T13 | 1835-2009 | Sentence | denotes | Finally, we show that two other I kappaB molecules, I kappaB beta and the recently identified I kappaB epsilon, are not degraded in the 1.3E2 cell line following stimulation. |
| T14 | 2010-2177 | Sentence | denotes | Our results demonstrate that 1.3E2 is a cellular transduction mutant exhibiting a defect in a step that is required by several different stimuli to activate NF-kappaB. |
| T15 | 2178-2331 | Sentence | denotes | In addition, this analysis suggests a common step in the signaling pathways that trigger I kappaB alpha, I kappaB beta, and I kappaB epsilon degradation. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 22-38 | cell_line | denotes | mutant cell line |
| T2 | 62-71 | protein | denotes | NF-kappaB |
| T3 | 221-242 | protein | denotes | nuclear factor kappaB |
| T4 | 244-253 | protein | denotes | NF-kappaB |
| T5 | 287-295 | protein | denotes | I kappaB |
| T6 | 297-306 | protein | denotes | NF-kappaB |
| T7 | 389-397 | protein | denotes | I kappaB |
| T8 | 417-426 | protein | denotes | NF-kappaB |
| T9 | 532-540 | protein | denotes | I kappaB |
| T10 | 640-682 | cell_line | denotes | 70/Z3-derived 1.3E2 murine pre-B cell line |
| T11 | 707-716 | protein | denotes | NF-kappaB |
| T12 | 843-856 | protein | denotes | interleukin-1 |
| T13 | 861-880 | RNA | denotes | double-stranded RNA |
| T14 | 882-896 | protein | denotes | I kappaB alpha |
| T15 | 1011-1025 | protein | denotes | I kappaB alpha |
| T16 | 1044-1047 | protein | denotes | p50 |
| T17 | 1051-1055 | protein | denotes | relA |
| T18 | 1083-1092 | protein | denotes | NF-kappaB |
| T19 | 1213-1221 | protein | denotes | I kappaB |
| T20 | 1287-1298 | cell_line | denotes | 1.3E2 cells |
| T21 | 1495-1503 | protein | denotes | I kappaB |
| T22 | 1525-1530 | cell_line | denotes | 1.3E2 |
| T23 | 1564-1569 | cell_line | denotes | 1.3E2 |
| T24 | 1606-1621 | cell_line | denotes | wild-type 70Z/3 |
| T25 | 1647-1718 | protein | denotes | human T-cell leukemia virus type 1 (HTLV-1)-derived Tax trans-activator |
| T26 | 1727-1736 | protein | denotes | NF-kappaB |
| T27 | 1749-1754 | cell_line | denotes | 1.3E2 |
| T28 | 1867-1885 | protein | denotes | I kappaB molecules |
| T29 | 1887-1900 | protein | denotes | I kappaB beta |
| T30 | 1929-1945 | protein | denotes | I kappaB epsilon |
| T31 | 1971-1976 | cell_line | denotes | 1.3E2 |
| T32 | 2039-2044 | cell_line | denotes | 1.3E2 |
| T33 | 2050-2078 | protein | denotes | cellular transduction mutant |
| T34 | 2167-2176 | protein | denotes | NF-kappaB |
| T35 | 2267-2281 | protein | denotes | I kappaB alpha |
| T36 | 2283-2296 | protein | denotes | I kappaB beta |
| T37 | 2302-2318 | protein | denotes | I kappaB epsilon |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-104 | Sentence | denotes | Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. |
| S2 | 105-255 | Sentence | denotes | Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). |
| S3 | 256-352 | Sentence | denotes | Associated with its inhibitor, I kappaB, NF-kappaB resides as an inactive form in the cytoplasm. |
| S4 | 353-492 | Sentence | denotes | Upon stimulation by various agents, I kappaB is proteolyzed and NF-kappaB translocates to the nucleus, where it activates its target genes. |
| S5 | 493-579 | Sentence | denotes | The transduction pathways that lead to I kappaB inactivation remain poorly understood. |
| S6 | 580-748 | Sentence | denotes | In this study, we have characterized a cellular mutant, the 70/Z3-derived 1.3E2 murine pre-B cell line, that does not activate NF-kappaB in response to several stimuli. |
| S7 | 749-988 | Sentence | denotes | We demonstrate that upon stimulation by lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced phosphorylation on serines 32 and 36. |
| S8 | 989-1153 | Sentence | denotes | Neither a mutation in I kappaB alpha nor a mutation in p50 or relA, the two major subunits of NF-kappaB in this cell line, accounts for this phosphorylation defect. |
| S9 | 1154-1375 | Sentence | denotes | As well as culminating in the inducible phosphorylation of I kappaB alpha on serines 32 and 36, all the stimuli that are inactive on 1.3E2 cells exhibit a sensitivity to the antioxidant pyrrolidine dithiocarbamate (PDTC). |
| S10 | 1376-1531 | Sentence | denotes | In contrast, stimuli such as hyperosmotic shock or phosphatase inhibitors, which use PDTC-insensitive pathways, induce I kappaB alpha degradation in 1.3E2. |
| S11 | 1532-1622 | Sentence | denotes | Analysis of the redox status of 1.3E2 does not reveal any difference from wild-type 70Z/3. |
| S12 | 1623-1834 | Sentence | denotes | We also report that the human T-cell leukemia virus type 1 (HTLV-1)-derived Tax trans-activator induces NF-kappaB activity in 1.3E2, suggesting that this viral protein does not operate via the defective pathway. |
| S13 | 1835-2009 | Sentence | denotes | Finally, we show that two other I kappaB molecules, I kappaB beta and the recently identified I kappaB epsilon, are not degraded in the 1.3E2 cell line following stimulation. |
| S14 | 2010-2177 | Sentence | denotes | Our results demonstrate that 1.3E2 is a cellular transduction mutant exhibiting a defect in a step that is required by several different stimuli to activate NF-kappaB. |
| S15 | 2178-2331 | Sentence | denotes | In addition, this analysis suggests a common step in the signaling pathways that trigger I kappaB alpha, I kappaB beta, and I kappaB epsilon degradation. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 20-38 | NP | denotes | a mutant cell line |
| C3 | 39-43 | NP | denotes | that |
| C4 | 62-71 | NP | denotes | NF-kappaB |
| C1 | 20-103 | NP | denotes | a mutant cell line that does not activate NF-kappaB in response to multiple stimuli |
| C5 | 221-254 | NP | denotes | nuclear factor kappaB (NF-kappaB) |
| C7 | 272-275 | NP | denotes | its |
| C6 | 272-285 | NP | denotes | its inhibitor |
| C8 | 287-295 | NP | denotes | I kappaB |
| C9 | 297-306 | NP | denotes | NF-kappaB |
| C10 | 389-397 | NP | denotes | I kappaB |
| C11 | 417-426 | NP | denotes | NF-kappaB |
| C12 | 462-464 | NP | denotes | it |
| C13 | 475-478 | NP | denotes | its |
| C14 | 493-518 | NP | denotes | The transduction pathways |
| C15 | 519-523 | NP | denotes | that |
| C17 | 617-634 | NP | denotes | a cellular mutant |
| C18 | 636-682 | NP | denotes | the 70/Z3-derived 1.3E2 murine pre-B cell line |
| C19 | 684-688 | NP | denotes | that |
| C20 | 707-716 | NP | denotes | NF-kappaB |
| C16 | 617-747 | NP | denotes | a cellular mutant, the 70/Z3-derived 1.3E2 murine pre-B cell line, that does not activate NF-kappaB in response to several stimuli |
| C21 | 882-896 | NP | denotes | I kappaB alpha |
| C22 | 970-987 | NP | denotes | serines 32 and 36 |
| C23 | 1011-1025 | NP | denotes | I kappaB alpha |
| C24 | 1044-1055 | NP | denotes | p50 or relA |
| C26 | 1083-1092 | NP | denotes | NF-kappaB |
| C25 | 1057-1092 | NP | denotes | the two major subunits of NF-kappaB |
| C27 | 1096-1110 | NP | denotes | this cell line |
| C28 | 1213-1227 | NP | denotes | I kappaB alpha |
| C29 | 1231-1248 | NP | denotes | serines 32 and 36 |
| C30 | 1250-1265 | NP | denotes | all the stimuli |
| C31 | 1266-1270 | NP | denotes | that |
| C32 | 1287-1298 | NP | denotes | 1.3E2 cells |
| C33 | 1389-1449 | NP | denotes | stimuli such as hyperosmotic shock or phosphatase inhibitors |
| C34 | 1451-1456 | NP | denotes | which |
| C35 | 1525-1530 | NP | denotes | 1.3E2 |
| C36 | 1564-1569 | NP | denotes | 1.3E2 |
| C37 | 1643-1718 | NP | denotes | the human T-cell leukemia virus type 1 (HTLV-1)-derived Tax trans-activator |
| C38 | 1749-1754 | NP | denotes | 1.3E2 |
| C39 | 1772-1790 | NP | denotes | this viral protein |
| C40 | 1857-1885 | NP | denotes | two other I kappaB molecules |
| C41 | 1887-1945 | NP | denotes | I kappaB beta and the recently identified I kappaB epsilon |
| C42 | 1967-1986 | NP | denotes | the 1.3E2 cell line |
| C43 | 2039-2044 | NP | denotes | 1.3E2 |
| C44 | 2102-2108 | NP | denotes | a step |
| C45 | 2109-2113 | NP | denotes | that |
| C46 | 2167-2176 | NP | denotes | NF-kappaB |
| C47 | 2231-2253 | NP | denotes | the signaling pathways |
| C48 | 2254-2258 | NP | denotes | that |
| C49 | 2267-2281 | NP | denotes | I kappaB alpha |
| R1 | C3 | C2 | coref-relat | that,a mutant cell line |
| R2 | C5 | C4 | coref-ident | nuclear factor kappaB (NF-kappaB),NF-kappaB |
| R3 | C7 | C5 | coref-pron | its,nuclear factor kappaB (NF-kappaB) |
| R4 | C8 | C6 | coref-appos | I kappaB,its inhibitor |
| R5 | C9 | C5 | coref-ident | NF-kappaB,nuclear factor kappaB (NF-kappaB) |
| R6 | C10 | C6 | coref-ident | I kappaB,its inhibitor |
| R7 | C11 | C9 | coref-ident | NF-kappaB,NF-kappaB |
| R8 | C12 | C11 | coref-pron | it,NF-kappaB |
| R9 | C13 | C11 | coref-pron | its,NF-kappaB |
| R10 | C15 | C14 | coref-relat | that,The transduction pathways |
| R11 | C18 | C17 | coref-appos | the 70/Z3-derived 1.3E2 murine pre-B cell line,a cellular mutant |
| R12 | C19 | C17 | coref-relat | that,a cellular mutant |
| R13 | C20 | C11 | coref-ident | NF-kappaB,NF-kappaB |
| R14 | C16 | C1 | coref-ident | "a cellular mutant, the 70/Z3-derived 1.3E2 murine pre-B cell line, that does not activate NF-kappaB in response to several stimuli",a mutant cell line that does not activate NF-kappaB in response to multiple stimuli |
| R15 | C23 | C21 | coref-ident | I kappaB alpha,I kappaB alpha |
| R16 | C26 | C20 | coref-ident | NF-kappaB,NF-kappaB |
| R17 | C25 | C24 | coref-appos | the two major subunits of NF-kappaB,p50 or relA |
| R18 | C27 | C16 | coref-ident | this cell line,"a cellular mutant, the 70/Z3-derived 1.3E2 murine pre-B cell line, that does not activate NF-kappaB in response to several stimuli" |
| R19 | C28 | C23 | coref-ident | I kappaB alpha,I kappaB alpha |
| R20 | C29 | C22 | coref-ident | serines 32 and 36,serines 32 and 36 |
| R21 | C31 | C30 | coref-relat | that,all the stimuli |
| R22 | C34 | C33 | coref-relat | which,stimuli such as hyperosmotic shock or phosphatase inhibitors |
| R23 | C35 | C32 | coref-ident | 1.3E2,1.3E2 cells |
| R24 | C36 | C35 | coref-ident | 1.3E2,1.3E2 |
| R25 | C38 | C36 | coref-ident | 1.3E2,1.3E2 |
| R26 | C39 | C37 | coref-ident | this viral protein,the human T-cell leukemia virus type 1 (HTLV-1)-derived Tax trans-activator |
| R27 | C41 | C40 | coref-appos | I kappaB beta and the recently identified I kappaB epsilon,two other I kappaB molecules |
| R28 | C42 | C38 | coref-ident | the 1.3E2 cell line,1.3E2 |
| R29 | C43 | C42 | coref-ident | 1.3E2,the 1.3E2 cell line |
| R30 | C45 | C44 | coref-relat | that,a step |
| R31 | C46 | C26 | coref-ident | NF-kappaB,NF-kappaB |
| R32 | C48 | C47 | coref-relat | that,the signaling pathways |
| R33 | C49 | C28 | coref-ident | I kappaB alpha,I kappaB alpha |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 22-38 | cell_line | denotes | mutant cell line |
| T2 | 62-71 | protein_complex | denotes | NF-kappaB |
| T3 | 150-162 | other_name | denotes | inflammation |
| T4 | 221-242 | protein_complex | denotes | nuclear factor kappaB |
| T5 | 244-253 | protein_complex | denotes | NF-kappaB |
| T6 | 287-295 | protein_molecule | denotes | I kappaB |
| T7 | 297-306 | protein_complex | denotes | NF-kappaB |
| T8 | 342-351 | cell_component | denotes | cytoplasm |
| T9 | 389-397 | protein_molecule | denotes | I kappaB |
| T10 | 417-426 | protein_complex | denotes | NF-kappaB |
| T11 | 497-518 | other_name | denotes | transduction pathways |
| T12 | 532-540 | protein_molecule | denotes | I kappaB |
| T13 | 640-682 | cell_line | denotes | 70/Z3-derived 1.3E2 murine pre-B cell line |
| T14 | 707-716 | protein_complex | denotes | NF-kappaB |
| T15 | 789-807 | lipid | denotes | lipopolysaccharide |
| T16 | 809-814 | other_organic_compound | denotes | Taxol |
| T17 | 816-841 | other_organic_compound | denotes | phorbol myristate acetate |
| T18 | 843-856 | protein_molecule | denotes | interleukin-1 |
| T19 | 861-880 | RNA_family_or_group | denotes | double-stranded RNA |
| T20 | 882-890 | protein_molecule | denotes | I kappaB |
| T21 | 1011-1019 | protein_molecule | denotes | I kappaB |
| T22 | 1044-1047 | protein_subunit | denotes | p50 |
| T23 | 1051-1055 | protein_subunit | denotes | relA |
| T24 | 1083-1092 | protein_complex | denotes | NF-kappaB |
| T25 | 1130-1152 | other_name | denotes | phosphorylation defect |
| T26 | 1184-1209 | other_name | denotes | inducible phosphorylation |
| T27 | 1213-1221 | protein_molecule | denotes | I kappaB |
| T28 | 1287-1298 | cell_line | denotes | 1.3E2 cells |
| T29 | 1328-1339 | other_organic_compound | denotes | antioxidant |
| T30 | 1340-1367 | other_organic_compound | denotes | pyrrolidine dithiocarbamate |
| T31 | 1369-1373 | other_organic_compound | denotes | PDTC |
| T32 | 1405-1423 | other_name | denotes | hyperosmotic shock |
| T33 | 1427-1449 | other_organic_compound | denotes | phosphatase inhibitors |
| T34 | 1461-1465 | other_organic_compound | denotes | PDTC |
| T35 | 1495-1503 | protein_molecule | denotes | I kappaB |
| T36 | 1525-1530 | cell_line | denotes | 1.3E2 |
| T37 | 1564-1569 | cell_line | denotes | 1.3E2 |
| T38 | 1606-1621 | cell_line | denotes | wild-type 70Z/3 |
| T39 | 1647-1681 | virus | denotes | human T-cell leukemia virus type 1 |
| T40 | 1683-1689 | virus | denotes | HTLV-1 |
| T41 | 1699-1702 | protein_molecule | denotes | Tax |
| T42 | 1727-1736 | protein_complex | denotes | NF-kappaB |
| T43 | 1749-1754 | cell_line | denotes | 1.3E2 |
| T44 | 1816-1833 | other_name | denotes | defective pathway |
| T45 | 1867-1875 | protein_molecule | denotes | I kappaB |
| T46 | 1887-1895 | protein_molecule | denotes | I kappaB |
| T47 | 1929-1937 | protein_molecule | denotes | I kappaB |
| T48 | 1971-1976 | cell_line | denotes | 1.3E2 |
| T49 | 2039-2044 | cell_line | denotes | 1.3E2 |
| T50 | 2050-2078 | protein_family_or_group | denotes | cellular transduction mutant |
| T51 | 2167-2176 | protein_complex | denotes | NF-kappaB |
| T52 | 2267-2275 | protein_molecule | denotes | I kappaB |
| T53 | 2283-2291 | protein_molecule | denotes | I kappaB |
| T54 | 2302-2310 | protein_molecule | denotes | I kappaB |
| T55 | 2319-2330 | other_name | denotes | degradation |